5 results match your criteria: "La Timone university hospital APHM[Affiliation]"
Article Synopsis
- Sleep disorders, particularly excessive daytime sleepiness, are prevalent in patients with atopic dermatitis, affecting 46.1% of those studied.
- This daytime sleepiness is linked to the severity of atopic dermatitis and negatively impacts patients' quality of life and overall well-being.
- The findings highlight the need for assessing and managing sleep issues in these patients, suggesting that targeted intervention programs could enhance their quality of life.
Impact of Atopic Dermatitis on Patients and their Partners.
Acta Derm Venereol
June 2023
Department of dermatology, Aix-Marseille University, La Timone university hospital, Marseille, France, CEReSS-EA 3279, health services and quality of life research centre, Aix Marseille University, dermatology department, La Timone university hospital APHM, 13385, Marseille, France.
Article Synopsis
- - Atopic dermatitis is a chronic skin condition that affects not only the patients but also their partners, yet its impact on partners has been under-explored.
- - A study involving 1,266 patient-partner pairs revealed that the severity of atopic dermatitis correlates with higher burden scores for both patients and their partners, with significant differences in burden levels among mild, moderate, and severe cases.
- - The research indicated that both patients and their partners experience impaired sleep quality, and the condition negatively affects sexual desire, reported by 39% of partners and 26% of patients.
Anti-BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis.
J Eur Acad Dermatol Venereol
June 2023
Univ Rouen Normandie, FOCIS Center of Excellence PAn'THER, Rouen, France.
Background: Adverse pregnancy outcomes (APO) occur in 35% of patients with pemphigoid gestationis (PG). No biological predictor of APO has been established yet.
Objectives: To assess a potential relationship between the occurrence of APO and the serum value of anti-BP180 antibodies at the time of PG diagnosis.
Burden of visible [face and hands] skin diseases: Results from a large international survey.
Ann Dermatol Venereol
June 2023
Clinique Dermatologique, University Hospital, Strasbourg, France.
Background: While numerous surveys over the last decade have evaluated the burden of skin diseases, none have focused on the specific impact of disease-location on the hands and face.
Aim: The purpose of our study was to evaluate the burden of 8 skin diseases on the multidimensional aspects of subjects' daily lives in respect to their location on visible body areas (face or hands) versus non-visible areas.
Methods: This was a population-based study in a representative sample of the Canadian, Chinese, Italian, Spanish, German and French populations, aged over 18 years using the proportional quota sampling method.
Methotrexate for idiopathic chronic eczematous eruption of aging.
Eur J Dermatol
December 2021
Department of dermatology, Aix-Marseille University, La Timone university hospital, Marseille, France, CEReSS-EA 3279, health services and quality of life research centre, Aix Marseille University, dermatology department, La Timone university hospital APHM, 13385, Marseille, France.